Position in GYRE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$170,022
+$22,955 QoQ
Shares Held
25,800
+22.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 60 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $177,004,891 across 155 Biotechnology names. GYRE ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in GYRE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,022 | 25,800 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $147,067 | 21,100 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $148,966 | 21,100 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $157,406 | 21,100 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $97,755 | 13,300 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||